Christophe Assenmacher
Queen Elisabeth Medical Foundation, Cliniques du Sud Luxembourg
Papers
5
Total Citations
72
H-Index
4
About
Dr. Christophe Assenmacher is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for prostate and bladder cancers, with a particular focus on optimizing patient outcomes and surgical techniques. His major contributions include pioneering the evaluation of the Retzius-sparing approach in robot-assisted radical prostatectomy (RsRARP), where his early learning curve study across three continents (39 citations) provided critical insights into how surgeons can adopt this nerve-sparing technique without compromising oncological control. Dr. Assenmacher has also been instrumental in defining the true morbidity of robot-assisted radical cystectomy with intracorporeal urinary diversion, using the Comprehensive Complication Index to offer a more nuanced assessment than traditional grading systems (8 citations). His work on cost-analysis across European countries (15 citations) has informed healthcare policy, while his multi-institutional registry studies on perioperative blood transfusions (7 citations) and acetylsalicylic acid continuation (3 citations) have directly impacted perioperative management protocols. By systematically addressing both functional and oncological outcomes, Dr. Assenmacher has helped establish evidence-based standards that reduce complications and improve recovery for patients undergoing complex robotic urologic surgeries.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5